Literature DB >> 6525346

Biochemical characterization of complex formation by human erythrocyte spectrin, protein 4.1, and actin.

C M Cohen, S F Foley.   

Abstract

Ternary complex formation between the major human erythrocyte membrane skeletal proteins spectrin, protein 4.1, and actin was quantified by measuring cosedimentation of spectrin and band 4.1 with F-actin. Complex formation was dependent upon the concentration of spectrin and band 4.1, each of which promoted the binding of the other to F-actin. Simultaneous measurement of the concentrations of spectrin and band 4.1 in the sedimentable complex showed that a single molecule of band 4.1 was sufficient to promote the binding of a spectrin dimer to F-actin. However, the molar ratio of band 4.1/spectrin in the complex was not fixed, ranging from approximately 0.6 to 2.2 as the relative concentration of added spectrin to band 4.1 was decreased. A mole ratio of 0.6 band 4.1/spectrin suggests that a single molecule of band 4.1 can promote the binding of more than one spectrin dimer to an actin filament. Saturation binding studies showed that in the presence of band 4.1 every actin monomer in a filament could bind at least one molecule of spectrin, yielding ternary complexes with spectrin/actin mole ratios as high as 1.4. Electron microscopy of such complexes showed them to consist of actin filaments heavily decorated with spectrin dimers. Ternary complex formation was not affected by alteration in Mg2+ or Ca2+ concentration but was markedly inhibited by KCl above 100 mM and nearly abolished by 10 mM 2,3-diphosphoglycerate or 10 mM adenosine 5'-triphosphate. Our data are used to refine the molecular model of the red cell membrane skeleton.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6525346     DOI: 10.1021/bi00320a029

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Control of band 3 lateral and rotational mobility by band 4.2 in intact erythrocytes: release of band 3 oligomers from low-affinity binding sites.

Authors:  D E Golan; J D Corbett; C Korsgren; H S Thatte; S Hayette; Y Yawata; C M Cohen
Journal:  Biophys J       Date:  1996-03       Impact factor: 4.033

2.  Human erythrocyte protein 4.1 is a phosphatidylserine binding protein.

Authors:  A C Rybicki; R Heath; B Lubin; R S Schwartz
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

3.  Structural protein 4.1R is integrally involved in nuclear envelope protein localization, centrosome-nucleus association and transcriptional signaling.

Authors:  Adam J Meyer; Donna K Almendrala; Minjoung M Go; Sharon Wald Krauss
Journal:  J Cell Sci       Date:  2011-04-12       Impact factor: 5.285

4.  Molecular defect in the membrane skeleton of blood bank-stored red cells. Abnormal spectrin-protein 4.1-actin complex formation.

Authors:  L C Wolfe; A M Byrne; S E Lux
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

5.  Phosphorylation-dependent perturbations of the 4.1R-associated multiprotein complex of the erythrocyte membrane.

Authors:  Emilie Gauthier; Xinhua Guo; Narla Mohandas; Xiuli An
Journal:  Biochemistry       Date:  2011-05-06       Impact factor: 3.162

6.  Interaction of the exported malaria protein Pf332 with the red blood cell membrane skeleton.

Authors:  Karena L Waller; Lisa M Stubberfield; Valentina Dubljevic; Donna W Buckingham; Narla Mohandas; Ross L Coppel; Brian M Cooke
Journal:  Biochim Biophys Acta       Date:  2010-02-02

7.  Decreased level of 2,3-diphosphoglycerate and alteration of structural integrity in erythrocytes infected with Plasmodium falciparum in vitro.

Authors:  M L Dubey; Ramakrishna Hegde; N K Ganguly; R C Mahajan
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

8.  The murine mutation jaundiced is caused by replacement of an arginine with a stop codon in the mRNA encoding the ninth repeat of beta-spectrin.

Authors:  M L Bloom; T M Kaysser; C S Birkenmeier; J E Barker
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

9.  Hemoglobin affinity for 2,3-bisphosphoglycerate in solutions and intact erythrocytes: studies using pulsed-field gradient nuclear magnetic resonance and Monte Carlo simulations.

Authors:  A J Lennon; N R Scott; B E Chapman; P W Kuchel
Journal:  Biophys J       Date:  1994-11       Impact factor: 4.033

10.  Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemia.

Authors:  E Shinar; E A Rachmilewitz; S E Lux
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.